Chemistry:Florensocatib
From HandWiki
Florensocatib is an investigational new drug that is being developed by Chiesi Farmaceutici S.p.A. for the treatment of bronchiectasis. It is a cathepsin C inhibitor.[1][2]
References
- ↑ "Florensocatib". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800065247.
- ↑ "Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies". The European Respiratory Journal. June 2026. doi:10.1183/13993003.00239-2026. PMID 42276744.
 |  |
